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Hemifistularin 3: a Degraded Peptide or Biogenetic Precursor? Isolation from a 
Sponge of the Order Verongida from the Coral Sea or Generation from Base 
Treatment of 11 -0xofistularin 3 
lnes Mancini,a Graziano Guella,a Pierre Laboute,6 Cécile Debitusb and Francesco Pietraa 
a Istituto di Chimica, Università degli Studi di Trento, 38050 Povo- Trento, Italy 
ORSTOM, Centre de Nouméa, B. P. A 5  Noumea Cédex, Nouvelle Calédonie 
Hemifistularin 3 1.0. contained in a new species of sponge of the family Aplysinellidae, order 
Verongida, from the Coral Sea, corresponds to the right half of 11-oxofistularin 3 6, also contained 
in this sponge, and from which it can be obtained in a peculiar base-catalysed degradation. This 
raises the question of whether or not hemifistularin 3 is the first example of a biogenetically 
degraded peptide, or rather an elaborated biogenetic precursor, in sponges of the order Verongida. 
The new compounds 19-deoxyfistularin 3 8 and 19-deoxy-1 1 -oxofistularin 3 9 have also been 
isolated from the same sponge. 
J 
-.. 
Sponges belonging to the order Verongida have yielded a wide 
variety of tyrosine metabolite,'" usually based on 3,Sdibromo- 
tyrosine or less frequently 3-bromo-,' 3-chlor0-,~ 3,S-dichlor0-,~ 
or 3-brom0-5-chloro-tyrosine.~ In many cases a single tyrosine 
-unit is involved, as with dibromoverongiaquinol 1 and 
aeroplysinin 1 ,  either dextro- (+)-2& or laevo-rotatory46 or of 
unspecified chirality.& Other metabolites entail two or more 
tyrosine units through either amide bonding, as in aerothionin 
( + )-3 and homoaerothionin 4 which also incorporate biogenic 
ami ne^,^ or ether bonds, as in the bastadins'" or fistularin 3 
5-67 * 
We report here on a novel decarboxylated dipeptide, isolated 
from a new species of the order Verongida from the Coral Sea, 
which corresponds to the right half of either fistularin 3 or 
I I-oxofistularin 3 and which can be obtained from the latter in 
a peculiar base-catalysed degradation. This raises intriguing 
questions about the biogenesis of these metabolites. We also 
report on two new fistularin 3 derivatives. 
Results and Discussion 
Extracts of this sponge, collected at two spots in the Coral Sea, 
proved to contain the long known dibromoverongiaquinol 
dextro-rotatory aeroplysinin 1 (+)-2,4 aerothionin (+)-3,' 
homoaerothionin 4,5" and the recently reported 1 I -oxofistularin 
3 6' and 11,19-dideoxyfistularin 3 7,*7 besides the new 19- 
deoxyhtularin 3 8 and 19-deoxy-l l-oxofistularin 3 9. 
More interestingly, our sponge proved also to contain the 
new compound 10, which, corresponding to the right half of 
eitherfistularin 3 or 1 1 -0xofistularin 3, was named hemifistularin 
3. 
Structural assignments of the fistularin 3 derivatives 6-9 were 
based on NMR data$ and on FABMS data for their products of 
spirooxazolidine ring opening. in the case of compounds 6 and 7 
this serves now only to confirm the assigned structures, spectral 
* No absolute configurational meaning is implied by the structural 
formulae in this paper, except for aeroplysinin 1 (+)-249.b and 
aerothionin ( +)-3.5b 
i Compounds 6 and 7 were reported '.* when we had already completed 
their structural assignment and were long awaiting biological screening 
from external laboratories. 
1 Inclhding 'H-lH COSY experimentsg for compounds 6-9 and 
hemifistularin 3 IO, 'H-I3C COSY experiments10" for compounds 6 
and 7, and the long-range variant o f  the latter ' O b  for compounds CIO.  
O OM8 
O O 
(+)-3 n = 4  
4 n = 5  
OMe OMe 
OMe 
10 
data being in accord with those already published.'** The 
assignments for compounds 8 and 9 were based on the 
observations that 'H NMR signals for the 19-CHOH and 11- 
' 
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"C and 'H NMR data for 19-deoxyfistularin 38and  19-deoxy-l I-oxofistularin 3 9 in (CD3),C0 
8 9 
Atom 
position 13C 'H" 1 'c IHb 
I ,  I '  
2, 2' 
3, 3' 
4,4' 
5, 5' 
6.6' 
7, 7' 
8, 8' 
9 ,Y  
IO 
Il 
I2 
13 
14.18 
-._ 15: 17 
16 
19 
20 
3-, 3'-Me0 
75.09,75.20 (d) 4.23,4.18 (dd, 8.1,0.9) 
122.10(s) 
148.75 (s) 
113.78 (s) 
132.28 (d) 6.56,6.52(d,J5., =J5:, =0.9) 
91.56,91.76(s) 
40.03.40.08 (t) 
155.14, 155.16 (s) 
160.00, 160.41 (s) 
43.49 (t) 3.50,3.70 (m) 
69.68 (d) 4.25 (m) 
75.79 (t) 4.03 (m) 
lS1.97(s) 
1 18.31 (s) 
134.14(d) 7.53 (s) 
139.88 (s) 
34.71 (t) 
40.91 (t) 3.58 (td, 7.0.6.0) 
60.19 (4) 
3.86 and 3.22,3.84 and 
3.18 (d, Jgsm 18.1) 
2.88 (t. Ji, .zo 7.0) 
3.78 (s), 3.73 (s) 
75.1 I ,  75.18 (d) 
148.73, 148.74 (s) 
113.85 (s) 
132.27, 132.28 (d) 
91.95.91.59 (s) 
39.87.40.09 (t) 
154.79, 155.16 (s) 
160.24, 160.03 (s) 
47.46 (t) 
200.87 (s) 
76.48 (t) 
151.23 (s) 
1 18.07 (s) 
134.21 (d) 
140.53 (s) 
40.85 (t) 
60.19 (4) 
122.11 (s) 
34.74 (t) 
4.23,4.18 (dd. 8.1,O.g) 
6.57 and 6.52 (d, JSml  = J5..] = 0.9) 
3.86 and 3.22.3.84 and 
3.16 (d, J,,, 18.1) 
4.60 (d, 6.0) 
4.75 (s) 
9a-H 7.86 (br t, &O), Ya-H 7.77 (br t, 6.9). 
CHOH functions of fistularin 3 S 6  are replaced in compound 9 
by, respectively, the signals for a methylene group (S, 2.91, as a 
tt for coupling to  20-H,) and a keto group (S, 200.87, s), whilst 
in compound 8 the signals for 19-CHOH are replaced by the 
signals for a methylene group (6,238) (Table 1). The structure 
of hemifistularin 3 10 was based on the NMR detection of single 
dibromospirocyclohexadienyl ring and trisubstituted phen- 
olic 'moieties. For the new compounds 8-10 a trans 
relationship between the OH group and the isoxazolidine 
oxygen atom was established by comparison of NMR data 
(Table i )  with those of synthetic cis, cis-aerothionin." 
These structural assignments were further substantiated by 
MS data. While hemifistularin 3 10 smoothly gave the 
molecular ion in FABMS (see Experimental section), meta- 
bolites 6-9 did not. Therefore, following literature indications 
for aerothionin 3 and fistularin 3 5,'' 1 1,19-dideoxyfistularin 3 7 
and 1Pdeoxyfistularin 3 8 were subjected to treatment with 3% 
methanolic KOH at reflux, followed by acidic work-up. This 
gave compounds 11 and 12, respectively, in the oximino E form 
(Scheme 1). Both these compounds gave the respective 
molecular ions in FABMS (see Experimental section). However, 
OMe 
HO 
Br 
0 r  
N- 
ÒMe - 11 R = H  - 12 R=OH i i 7 8 
Scheme 1 
followed by acidic work-up. 
Reagents und conditions: i, 3% KOH. MeOH. reflux, 2 h; 
when either 11-oxofistularin 3 6 or 19-deoxy-I I-oxofistdarin 3 
9 was subjected to the same alkaline treatment, O-C(l2) bond 
breaking unexpectedly occurred. This is indicated in Scheme 2 
where it is seen that base-treatment of compound 6 at room 
temperature, followed by acidic work-up, fed to hemifistularin 3 
10 and its oxime (E)-13. The latter structure was established by 
1 D NMR data (see Experimental section), 'H-'H COSY and 
long-range 'H-"C COSY experiments. Compound 9 gave a 
mixture of the spirooxazolidine 14 and oxime (E)-15 on similar 
alkaline treatment, while changing to reflux conditions 
followed by neutral work-up gave products (E)-15 and (2)-15 
only (5: l).* These results show that base-induced O-C(IZ) 
bond breaking with 1 I-oxofistularins 3 is an easier process than 
is spirooxazolidine ring opening. 
It is interesting that the spirooxazolidine product of base- 
catalysed degradation of I I-oxofistularin 3 6 corresponds to 
hemifistularin 3 10. As both compounds are present in our 
sponge, the question is raised as to if hemifistularin 3 is a 
product of biogenetic degradation of 1 1-oxofistularin 3 or 
rather an elaborated biogenetic precursor of it. In either case 
these are uncommon observations for tyrosine metabolites of 
sponges of the order Verongida. Viewing compound 10 as a 
biogenetic precursor, the O-C( 12) bond might have been 
established via nucleophilic displacement of phosphorylated 
serine's hydroxy group followed by decarboxylation. Viewing 
compound 10 alternatively as a degradation product, its 
generation from I I-oxofistularin 3 may be imagined in analogy 
* NMR data for compounds 6and 7 are also reported (see Expenmental 
section), since they are available from the literat~re,'.~ but in other 
solvents, which does not allow safe structural comparisons. The E@ 
stereochemistry of the oxime was established by comparison of NMR 
data with those reported for the oximes of brominated tyrosine 
met aboli te^.^^.^^.^^ Diagnostically important ish, for the benzylic C-l I 
in compounds (E)-13 and (E)-IS (25.56 t and 25.71 t, respectively) and 
for C-7 and C-7' in compounds I I  and 12 (25.72 t and 25.67 t, res- 
pectively) in comparison with the corresponding values for the 2 isomer 
(37.5 t). l 3  Our observation that in (CD,)2C0 both the benzylic protons 
and 13-H for compound (Z)-15 resonate at higher field than do  the 
corresponding protons for the E isomer is in accord with NMR 
observations in CDC13CD,0D mixtures.13 It is also relevant that for 
thezisomer thereisconcentration dependenceofh, for OH groups, very 
likely reflecting H-bonding between theoximeOH and carbonyl oxygen. 
J. CHEM. SOC. PERKlN TRANS. I 1993 3123 
HO 
ÒMe 
6 i - 10 R=OH i ( E ) - 1 3  R=OH 
+ 14 R = H  (E )-15 R =  H 
(E )-15 + (Z )-I5 R = H, 53  
Scheme 2 Numbering is for convenience. Reugenis undcondirions: i, 3% KOH, MeOH, room temp., overnight; followed by acidic work-up; ii, 3% 
ICOH, MeOH, reflux, 2 h; followed by neutral work-up. 
with that of ß-naphthol on treatment of its phenacyl ethers with 
5% ethanolic alkali.' ,** 
In cytotoxicity screenings, the most active of the metabolites 
of these sponges proved to be 1 I-oxofistularin 3 6 with 100% 
inhibition of KB cells in culture at 7 pg cmU3. Antiviral activity 
-of this compound was also reported.' 
Experimental 
Genera[.-All evaporations were carried out at reduced 
pressure. M.p.s were measured out with a Kofler hot-stage 
microscope and are uncorrected. Flash chromatography (FC) 
was performed on Merck Si-60, 15-25 Fm; TLC on Merck 
Kieselgel 60 PF,,, plates; and reversed-phase HPLC on 25 x 1 
cm columns filled with either Merck LiChrosorb RP18 (7 pm) 
or Merck LiChrosorb RP-8 (7 pm), with UV monitoring at  L 
254 nm, and solvent flux 5 cm3 min-'. UV spectra were recorded 
on a Perkin-Elmer Lambda-3 spectrophotometer. IR spectra 
were taken on a Perkin-Elmer 337 spectrometer. NMR spectra 
were recorded in (CD3),C0 with a Varian XL-300 spec- 
i trometer, 'H at 299.94 MHz, 13C at 75.43 MHz; &values are 
reported with respect to internal SiMe, (6 O) and J-values in Hz; 
multiplicities from DEPT l 6  assignments confirmed by 'H-I3C 
COSY." Optical rotation data were obtained with a JASCO- 
DP-181 polarimeter; [x]-values are given in IO-' deg cm2 g-l. 
Mass spectra (EI, unless otherwise stated) were taken with a 
Kratos MS80 mass spectrometer with home-built data system. 
FAB spectra were taken with the same apparatus equipped with 
a Vacumetrics DIP gun. 
Collecrion. Tmonony  und Isolation.-The sponge was first 
collected by SCUBA diving on 20 March 1988 at a depth of 53 
m on the external part of the south New Caledonian Grand 
Récif (collection R193!504M. 3 kg fresh weight. 390 g freeze- 
dried powder) and then on I I  March 1989 at the Récif de 
Nokanhui, Ile des Pins (collection R246/552M, 3 kg fresh 
weight. 500 g freeze-dried powder). The two collections proved 
tocontain the samesecondary metabolites, although in different 
relative proportions. Sample R 193/504M was examined by 
Prof. C. L&i. who retains a voucher specimen, and classified as 
* Possibly these processes are initiated by deprotonation of the 
activated methylene group (12- H L  in 1 I-oxofistularins 3 6 )  followed by 
departure ofphenolate to leave a carbonyl-stabilized carhene. However, 
no carboxylic ester from the expected Wolff rearrangement was 
isolated. 
a new species, formerly considered as a Verongia sp. [= 
ApIysina = Verongula]. The sponge, unlike typical Verongia, 
revealed a fully dendritic fibrous skeleton and therefore must 
be classified in the family Aplysinellidae Bergquist, order 
Verongida. The sponge was immediately freeze-dried and 
freeze-dried powder (310 g) was then extracted (MeOH) and the 
extract was evaporated to give a residue (16.1 g), which was 
extracted (EtOAc) to give a residue (7.15 g). This was subjected 
to FC, first with hexane-Et20 (7: 3), then hexane-EtOAc 
(gradient elution), with fractions (100 cm3) collected. Fractions. 
18-20 were evaporated to give a residue (0.39 g), which was: 
subjected to RP-8 HPLC with MeCN-water (55:45) to give 
compounds 10 ( t R  5.5 min, 24 mg). 6 (zR 9.4 min, 37 mg), 8 (tR 
13.5 min, 2 mg), 9 (rR 14.5 min, 11  mg) and 7 (tR 18.4 min, 43 
mg). Fractions eluted with EtOAc were evaporated to give a 
residue (1.59 g), which was subjected to further FC. The eluates, 
with hexane-Et,O (1 : 1) were evaporated to give a residue (1.15 
g), which was subjected to RP-8 HPLC with MeCN-water 
(1 : 1) to give compounds (+)-2 (t,  3.5 min), further purified on 
elution with MeCN-water (3:7) ( rR  8.1 min, 3.0 mg), 4 (tR 6.8 
min, 4.0 mg), (+)-3 (IR 10.4 min, 3.5 mg). Head fractions from 
the last process were combined, evaporated, and subjected to 
RP-8 HPLC with MeCN-water ( 1  5 : 85) to give compound 1 (tR 
10.0 min, 34 mg). 
1 1 -0mfisrulurin 3 6.  Powder. [a]$' + 156 (c 0.7. acetone) 
(lit.,' + 130,cO.l. MeOH);&775.29(d,C-I and I'), 122.1 I (s,C- 
2and 2'). 148.82(s,C-3and 3'). 1 l3.85(s,C-4and4'), 132.34and 
132.23 (d, C-5 and Sf), 92.04 and 9 I .86 (s, C-6 and 6'). 39.99 and 
39.89 (t. C-7 and 7'). 154.80 and 155.16 (s, C-8 and 8'). 160.29 
and 160.48 (s, C-9 and 9'). 47.52 (I, C-IO), 200.82 ( s ,  C-Il), 
76.52 (t, C-12), 151.93 (s, C-13). 118.11 (s, C-14 and -IS), 
131.55(d,C-15and-17). 143.93(s,C-16),71.46(d,C-19),47.60 
(t, C-20) and 60.23 (q, 3- and 3'-MeO); 6, 4.23 and 4. I8 (2 dd, 
J~.OH~.~.J,.,~.~.J,.OHS.I,J,.~O.~, I-and l'-H),6.56and6.52 
(2d. J5., = J , . . , .  = 0.9, 5- and Y-H), 3.86-3.22 and 3.84-3.18 
(2 couples of d, Jpcm 18.1. 7- and 7'-H,), 4.60 (d, J,o.,,N 5.8, 10- 
H2), 4.76 (s. 12-H2), 7.68 (s, 15- and 17-H), 4.92 (td, J19.20 7.2. 
J,Q.otl 4.3. 19-H), 3.61 and 3.19 (m, 20-H,), 5.44 and 5.47 (two 
d, JoH.~ = JO".,. = 8.1, 1- and l'-OH), 3.72 (s, 3- and 3'-Me0), 
7.58 and 7.69 (2 br t, J,,N.10 = JIIN.,,, = 5.8,9a- and 9'a-H) and 
I 1,I9- Dideoxyfisrulurin 3 7. Powder, m.p. 146 "C (from 
hexane-Et,O); [ZIA' + 150 (c 2.0, acetone) (l it . .8 +98.5, 
c 0.1); Sc 75.28 (d, C-I), 75.33 ( s ,  C-I'), 122.07 (C-2 and -2'), 
148.77 (s, C-3 and -3'), 113.81 ( s .  C-4 and 4'), 132.37 (d, C-5), 
132.30 (d. C-5'). 91.67 ( s ,  C-6 and -6'), 40.13 (t, C-7). 40.09 (t, 
5.08 (d. JOH.19 4.3, 19-OH). 
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C-7'), 155.24(~, C-8)- 155.14(~, C-S'), 160.07 (s, C-9), 160.01 (s, 
C-9'), 37.47 (t, C-IO), 30.55 (t. C-l I) ,  72.16 (s, C-12), 152.30 ( s ,  
C-13), 118.48 (s, C-14 and -18), 134.06 (d, C-15 and -17), 
139.63 (s, C-l6), 34.75 (t. C-19), 40.96 (t. C-20) and 60.21 (q.3- 
and 3'-Me0); 6, (coupling patterns are reported only if they 
differ from those for compound 6) 4.17 and 4.18 (dd, J,.,, 
8.1. J1.5 0.9, JI-OH 8.1, J I . ,  0.9, 1- and I'-H), 6.50 and 6.52 (5- 
and 5'-H), 3.84-3.18 and 3.82-3.16 (7- and 7'-H), 3.60 (4, 
J l 0 . l 1  z JIO.,, = 6.1, 10-H~). 2.13 (quint, Jll .10 = = 
6.1, II-H,), 4.08 (t. JI2." 6.1, 12-H,), 7.51 (15- and 17-H), 
5.44 ( I -  and l'-OH), 3.72 (s, 3- and 3'-Me0), 7.77 (br t, JHN." 
19-Deoxyfistularin 3 8. Powder; TLC (Et20) R, 0.45; [a]? + 
155 (c 0.17, acetone) (Found: C,. 34.1; H, 2.8; N, 5.2. 
C31H30Br6N4010 requires C, 33.9; H, 2.7; N, 5.1%); 
L,,,(MeOH)/nm 283 (&/dm3 mol-' cm-' 10 400), 235 (22 000) 
and 206 (60400); vmaX(Nujol)/cm-' 3400 br, 1650, 1590, 1535, 
E450 and 1050;mlz 351,349,347 (3,6,3%), 336,334,332(2,5,2), 
323,321,319 (1,2, l), 308,306,304(3,6,3), 307,305,303 (6, 12, 
6) and 267, 265,263 (2, 3,2). 
19-Deoxy-1 I-oxofstularin 3 9. Powder; TLC (Et,O) R, 0.65; 
[a];' + 136 (e 0.2, acetone) (Found: C, 33.8; H, 2.5; N, 5.2. 
C,,H,,Br,N4010 requires C, 34.0; H, 2.6; N, 5.1%); 
L,,,(MeOH)/nm 280 (&/dm3 mol-' cm-' 3400) and 205 (18 500); 
v(Nujol)/cm-' 3400 brj 1725, 1650, 1590 and 1530; m/z 35 1,349, 
347 (2,4,2%), 336,334,332 (2,4,2), 323,321,319 (4,9,5), 308, 
306,304 (6, 12, 6) and 267,265,263 (6, 12,6). 
Hemìjîstularin 3 10. Powder; m.p. 73-75 "C (from hexane/ 
Et,O); [a];' + 110(c0.2,acetone)(Found:C,31.9;H,2.5;N,4.2. 
(MeOH)/nm 281 (&/dm3 mol-' cm-' 6900) and 207 (39200); 
v(Nujol)/cm-' 3350 br, 1660, 1590,1540, 1270,1220 and 1095; 
6, 150.72 (s, C-1), 1 11.38 (s, C-2 and -6), 130.90 (d, C-3 and -9, 
2.86 (L J i g . 2 0  7.0, 19-H2), 3-58 (td, J20.19 7.0, J Z O , H N  6.0,20-H,), 
6.1,9a-H) and 7.72 (br t, J H N . ~  6.0,9'a-H). 
C , , H , ~ B ~ ~ N Z O ~  requires c ,  31.9; H, 2.4; N, 4.1%); LW,- 
138.50 (s,  C4), 71.43 (d, C-7), 47.71 (t, C-8), 160.42 (s, C-9), 
155.14(~,C-10),40.08(t,C-l1),91.84(5,C-12), 13 .27(d,C-l3), 
I13.9O(~,C-14), 148.78(~,C-15), 122.15(~,C-16),75.21 (d,C-17) 
and60.22(q,MeO);6,7.57(~,3-and5-H),4.84(ddd,J7.3,6.4 
and 3.8,7-H), 3.58 and 3.45 (2 ddd, J 13.5,6.4 and 5.8 a n d J  13.5, 
7.3. 5.8, 8-H2), 3.83 and 3.17 (2d, Jgem 18.2, 11-H,), 6.52 (d, 
OH), 5.02(d,JOH.7 3.8,7-OH), 7.69(brt,JH,,5.8, HN),3.72(s, 
OMe) and 5.48 (d, JOH.17 7.8, 17-OH); m/z (glycerol-MeOH- 
H +, FAB) 676.8 (MH', 0.2%, as the centre of a cluster of ions); 
(3-nitrobenzyl alcohol; FAB) 698.6 (MNa', 1.0% as the centre 
of a cluster of ions) and 658.6 (MH+ - H,O, 1.1% as a 
quintet). 
J~3.170-9,13-H),4.18 (ddrJ17,0H 7.8,J17.13 0.9,17-H),3.79(~, 1- 
Alkaline Treatment of 1I-O.rofistularin 3 6.-A solution of 
I 1 -oxofistularin 3 6 (1 1 mg) in 3% methanolic KOH (2 cm3)- 
water (0.5 cm3) was stirred at room temp. until complete 
disappearance (overnight. TLC monitoring). The mixture was 
then acidified, evaporated and the residue was extracted 
(EtOAc), and the extract was evaporated to give a residue, 
which was subjected to RP-8 HPLC with MeCN-water (55:45) 
to give compound 10 (lR 5.8 min, 2.8 mg) (identical with 
the natural product) and (E)-13 ( r R  10.0 min, 2.3 mg) as a 
powder. 
Data of oxime (E)-13: [z];' +20, [.If& +71 ( c  0.05, 
acetone); S, 150.66 (s, C- 1 ), 1 I 1.24 (s, C-2 and -6), 130.79 (d, C-3 
9). Ij4.54(s.C-10).?5.56(t.C-l I ) ,  121.79(s,C-12), 134.89(d,C- 
13). 108.8 I (s, C- 14). 154.74 (S, C- 15). 106.76 (s. C-I 6), 151 .O5 (s, 
C-17) and 60.54 (q, MeO); (SH 7.57 (s, 3- and 5-H). 4.88 (dd, 
J 7 . t ( u  = J7.J = J7.Rh = 3.3. 7-H), 3.64 and 3.48 (2 ddd, J 13.5, 
6.2.7.5andJ13.5,6.3,3.3.8-H2),3.81 (s, ll-H2).7.59(s, 13-H), 
3.80(s,OMe)and8.00(brt.6.2,HN);m/z598.596(1, 1%),584, 
582 ( I .  I ) ,  568. 566 (0.5.0.5). 351,349.347 (29. 60,31). 336.334, 
and-5). 138.11 (~.C-4),70.85(d,C-7).47.79(t.C-8),166.57(~,C- 
332 (28,54,27), 295,293,291 (14,26, 14), 283,281,279 (3,6,4) 
and 267, 265, 263, (7, 12,7). 
Alkaline Treatment of 1 I .  19-Dideoxyjstularin 3 7.-A 
solution of compound 7 ( I O  mg) in 3% methanolic KOH (2 
cm3)-water (0.5 cm3) was heated at reflux for 2 h, with 
monitoring by TLC. The solvent was evaporated off and the 
residue was acidified, then extracted (EtOAc). The extract was 
evaporated and the residue was subjected to RP-8 HPLC with 
MeCN-water (7: 3). 6 cm3 min'', to give compound 11 (tR 14.4 
min, 7.3 mg) as a powder, m.p. 100-102 "C (from MeOH) (lit.,' 
90-93 OC); SC 151.18 (s, C-l and -l'), 106.72 (s, C-2 and -2'). 
154.65 (s, C-3 and -3'), 108.70 (s, C-4 and -4'), 134.99 (d, C-5 and 
-59, 121.91 (s, C-6 and -6'), 25.72 (t, C-7 and -7'), 154.60 (s, C-8 
and -S'), 166.55 (s, C-9 and 97, 37.98 (t, C-IO), 30.55 (t, C-1 l), 
71.97 (t, C-l2), 151 .I 8 (s, C-l3), 1 18.47 (s, C-14 and -1 8), 134.04 
(d, C-15 and -17), 139.47 (s, C-16), 34.43 (t, C-19) and 41.34 (t, 
C-20); 6, 7.58 and 7.56 (s, 5- and 5'-H), 3.80 (s, 7- and 7'-H,), 
3.64 (td, Jlo.ll 6.9, J1O.HN 6.0, 10-H,), 2.11 (quint, Jll,lo = 
Jll . l ,  = 6.9, fl-H2),4.03(t,J,2~116.9, 12-H2),7.48(s, 15-and 
20-H,), 3.78 and 3.82 (s, 3- and 3'-Me0), 1 1 .O5 and I 1.62 (br s, 8- 
and 8'-NOH) and 8.19 and 8.16 (br t, JHN,IO 6.0,9a-H; and br t, 
JHN.20 6.0, 9'a-H); m/z (3-nitrobenzyl alcohol, FAB) 1082.8 
(MH+, 1 .O% as the centre of a cluster of ions). 
17-H),2.89(t,Ji9.206.9,19-H,),3.62(td,J2o,1g6.9, J20.HN-9.a6.0, 
i Alkaline Treatment of 19-Deoxyfstularin 3 & - O n  treatment 
as above for compound 7, followed by purification via RP-18 
HPLC with MeCN-water (3 : 2), compound 12 ( t R  22.4 min) was 
obtained in 72% yield as a powder, m.p. 114-1 18 "C (from 
MeOH); [a];' f2.2, [a]:& + 17.2 (c  0.18, acetone); 6, 151.16 
and 15 I .  12 (s, C- 1 and - 1 '), 106.64 (s, C-2 and -2'), 154.71 (s, C-3 
and -3'), 108.78 (s, C-4 and -4'), 134.93 (d, C-5 and -5'),121.84 (s, 
C-6 and -6'), 25.67 (t, C-7 and -7'), 154.61 (s, C-8 and -S'), 166.60 
(s, C-9 and -9'), 43.60 (t, C-IO), 69.18 (d, C-Il), 75.47 (t, C-12), 
151.16 (s, C-13), 118.26 (s, C-14 and -IS), 134.04 (d, C-15 and 
-l7), 139.52 (s, C-16), 34.34 (t. C-19), 41.27 (t, C-20) and 60.52 
(4. MeO); 6, 7.58 and 7.60 (s, 5- and 5'-H), 3.82 (s, 7- and 7'- 
H2), 3.55 and 3.75 (m, IO-H,), 4.25 (m, 11-H), 4.00 (m, 12-H2), 
7.50 (s, 15- and 17-H), 2.89 (t, J19,20 6.9, 19-H,), 3.62 (td, 
JzOs19 6.9, J20.Ht.4 6.0,20-H,), 3.79 (s, 3-and 3'-OMe), 11.69 and 
10.63 (br s, 8- and 8'-NOH) and 8.18 and 7.99 (br t, J20.HN-9'a 
6.0 and br t, JIO.HN-qa  6.0, 9a- and 9'a-H); m/z (3-nitrobenzyl 
alcohol, FAB) 1098.9 (MH +, as centre of a cluster of ions). 
Alkaline Treatment of 19- Deoxy- 1 I-oxojstularin 3 9.-19- 
Deoxy-I 1-oxofistularin 3 9 (6 mg, 0.005 mmol), on treatment 
identical with that for compound 6 above, followed by RP-8 
HPLC with MeCN-water (3 : 2), gave compound 14 (tR 8.9 min) 
and oxime (E)-15 (rR 12.2 min). In another experiment, 
compound 9 was stirred in 3% methanolic KOH at reflux for 
2 h, the mixture was then neutralized, evaporated, and 
extracted (EtOH) and the residue obtained on evaporation 
was subjected to HPLC under the same conditions as above 
to give oxime (Z)-15 ( I R  1 1  .O min) and oxime (E)-15 in 1 : 5 
molar ratio. 
Dataofcompound 14:S,, 7.60(s, 3-and5-H), 2.90(t, J7.' 7.0, 
7-H,),3.40(m,8-H1),3.83and3.16(2d,Jg,, 18.0, I I-H2),6.53 
(brs. 13-H),4.16(brd,J,,,,,,8.0, 17-H),8.12(brs, I-OH),7.66 
(br t. JHN.8 6.0, Sa-H), 3.73 (s, MeO) and 5.45 (d, 8.0, 
Data of oxime (E)-15 [data for (2)-15 within square 
brackets]:& 149.98 (s. C-I ), I 1 1.32 (s, C-2 and -6), 133.41 (d, C- 
3 and -5) .  134.53 (s. C-4). 34.14 (t, C-7), 41.58 (t, C-8). 166.59 (s, 
C-13). 108.83(s,C-14), 154.39(s,C-15), 106.70(~,C-16), 151.21 
(s, C-17) and 60.54 (q, Me0);6,7.41 [7.41] (s, 3- and 5-H), 2.82 
17-OH). 
C-9), 154.40(~,C-10),25.71 (t,C-I I ) ,  121.86(~,C-12), 134.99(d, 
L2.803 (t. J7.8 6.9. 7-H,). 3.56 [3.S2] (9, J B , ,  JB,HN = 6.9, 
J .  CHEM. soc. PERKIN TRANS. I 1993 
S-H,), 3.80 C3.781 ( s ,  1 I-HZ), 7.53 C7.451 ( s ,  13-H), 8.02 C7.871 
(m, H N )  a n d  3.79 C3.771 (s,  MeO); ni/= (glycerol-thiogly- 
cerol, FAB) 660.7 C660.81 (MH’, 8 [I]). 
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